Back
Relay Therapeutics 10K Form
Buy
52
RLAY
Relay Therapeutics
Last Price:
5.95
Seasonality Move:
2.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RLAY News And Ratings
See the #1 stock for the next 7 days that we like better than RLAY
RLAY Financial Statistics
Sales & Book Value
| Annual Sales: | $25.55M |
|---|---|
| Cash Flow: | $-75.31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.03 |
| Price / Book: | 1.23 |
Profitability
| EPS (TTM): | -2.61000 |
|---|---|
| Net Income (TTM): | $-345.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Relay Therapeutics Earnings Forecast
Key Relay Therapeutics Financial Ratios
- The Research & Development expenses have been 1,291.86% of Revenue.
- The Net Earning history of RLAY is -1,338.66% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Relay Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RLAY |
| CUSIP: | 75943R |
| Website: | relaytx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RLAY Technical Analysis vs Fundamental Analysis
Buy
52
Relay Therapeutics (RLAY)
is a Buy
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Buy
The current Relay Therapeutics [RLAY] share price is $6.16. The Score for RLAY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.